Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

Lancet
Salmaan KeshavjeeSonya S Shin

Abstract

Mycobacterium tuberculosis strains that cause untreatable drug-resistant disease are a threat worldwide. We describe the treatment, management, and outcomes of patients with extensively drug-resistant tuberculosis in Tomsk, Russia. We undertook a retrospective cohort study of 608 patients with multidrug resistant tuberculosis who had treatment in civilian or prison services, between Sept 10, 2000, and Nov 1, 2004, according to the treatment strategy recommended by WHO. Clinical characteristics, management practices, and treatment outcomes of patients with extensively drug-resistant (XDR) tuberculosis and non-extensively drug-resistant (non-XDR) tuberculosis are described. The main outcome was the frequency of poor and favourable outcomes at the end of treatment. Of 608 patients with multidrug resistant tuberculosis, 29 (4.8%) patients had baseline XDR tuberculosis. Treatment failure was more common in patients with XDR tuberculosis than in those with non-XDR tuberculosis (31%vs 8.5%, p=0.0008). 48.3% of patients with XDR tuberculosis and 66.7% of patients with non-XDR tuberculosis had treatment cure or completion (p=0.04). The frequency and management of adverse events did not differ between patients with XDR and non-XDR tuberc...Continue Reading

Citations

Dec 4, 2010·Inflammopharmacology·Amitabha Chakroborty
Oct 12, 2010·Irish Journal of Medical Science·M B O'Connor
Oct 22, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Wanitchaya KittikraisakJay K Varma
Dec 17, 2008·Nature Reviews. Microbiology·Christopher Dye
Apr 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sanjay BasuAlison P Galvani
Oct 26, 2011·The Journal of Infectious Diseases·David A J Moore, N Sarita Shah
Nov 21, 2012·The Journal of Infectious Diseases·Neel R GandhiN Sarita Shah
Jun 18, 2009·Current Opinion in Infectious Diseases·Sheela ShenoiGerald Friedland
Jun 16, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Eric L NuermbergerWing Wai Yew
Sep 5, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kwok-Chiu Chang, Wing-Wai Yew
Sep 2, 2010·Antimicrobial Agents and Chemotherapy·Julien PoissyNicolas Veziris
Mar 13, 2010·American Journal of Respiratory and Critical Care Medicine·Doh Hyung KimTae Sun Shim
Apr 24, 2010·American Journal of Respiratory and Critical Care Medicine·Sonya S ShinTed Cohen
Jan 19, 2012·PloS One·Wanitchaya KittikraisakSara J Whitehead
Jan 8, 2011·The American Journal of Tropical Medicine and Hygiene·Sanjay BasuMartin McKee
Sep 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Sarita ShahMercedes C Becerra
Sep 6, 2014·Journal of Global Infectious Diseases·Parviz MohajeriAbbas Farahani
Oct 21, 2014·Expert Opinion on Pharmacotherapy·Yong-Soo KwonWon-Jung Koh
Nov 19, 2015·Expert Opinion on Investigational Drugs·Yong-Soo Kwon, Won-Jung Koh
Feb 26, 2016·Mayo Clinic Proceedings·John W Wilson, Dean T Tsukayama
Dec 15, 2010·Lancet·Helen Cox, Gilles van Cutsem
Oct 13, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·M J Mellado PeñaUNKNOWN Grupo de Trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica
Apr 7, 2009·Lancet·Hans L Rieder
Feb 28, 2009·The Lancet Infectious Diseases·Evan W OrensteinAlison P Galvani
Jan 6, 2009·Lancet·Deepak AggarwalAshok K Janmeja
Jan 6, 2009·Lancet·Jussara Munareto SilvaAlexandre P Zavascki
Aug 30, 2008·Lancet·Helen Cox, Cheryl McDermid
Mar 3, 2015·Revue de pneumologie clinique·A S BakayokoE Aka-Danguy
Jul 24, 2015·The Journal of Antimicrobial Chemotherapy·Byeong-Ho JeongWon-Jung Koh
May 19, 2010·Expert Review of Respiratory Medicine·Alberto MatteelliGiovanni Battista Migliori
Jan 26, 2010·Medicinal Research Reviews·Francis E UmesiriSteven J Sucheck
Jun 29, 2015·The Indian Journal of Tuberculosis·Joyce Felicia VaghelaAnuj K Bhatnagar
Apr 15, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gustavo E VelásquezSalmaan Keshavjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

© 2022 Meta ULC. All rights reserved